• LAST PRICE
    0.7694
  • TODAY'S CHANGE (%)
    Trending Up0.0225 (3.0125%)
  • Bid / Lots
    0.7225/ 12
  • Ask / Lots
    0.7598/ 12
  • Open / Previous Close
    0.7306 / 0.7469
  • Day Range
    Low 0.7224
    High 0.7700
  • 52 Week Range
    Low 0.6002
    High 5.8200
  • Volume
    144,873
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.7469
TimeVolumeNGM
09:32 ET2400.7306
09:35 ET1000.749
10:26 ET1190.749
10:40 ET5900.73453
10:42 ET1000.7487
10:45 ET1000.735
10:47 ET4900.7345
10:49 ET17000.7294
10:51 ET1000.7224
10:56 ET1000.7487
10:58 ET1000.75
11:02 ET1000.7492
11:18 ET2000.7488
11:25 ET2120.724101
11:30 ET1000.75
11:32 ET1000.7277
11:34 ET3560.7376
11:36 ET42780.7482
11:41 ET7000.75
11:43 ET1000.7389
11:45 ET2000.728
11:50 ET1000.75
11:54 ET1000.739
11:56 ET68020.7402
11:57 ET38500.76
11:59 ET3000.76
12:01 ET2000.751
12:12 ET7000.7619
12:26 ET80050.769999
12:28 ET12000.761
12:30 ET4000.761
12:37 ET3000.7606
12:39 ET1000.7609
12:42 ET3000.761
12:44 ET1000.7611
12:48 ET1000.7627
12:50 ET6000.7648
12:51 ET1360.7621
12:55 ET1000.762
01:00 ET8830.7632
01:02 ET42060.7632
01:04 ET1000.7632
01:06 ET12030.7627
01:08 ET16940.7524
01:15 ET5000.7524
01:22 ET3410.76
01:24 ET5000.752
01:26 ET25500.745
01:27 ET2000.745
01:31 ET2000.74
01:36 ET5000.763
01:38 ET1000.7401
01:42 ET3340.7516
01:45 ET2000.763
01:54 ET2000.7401
01:56 ET44080.7401
02:07 ET1000.7515
02:12 ET1000.7401
02:14 ET1000.7401
02:16 ET15000.74
02:18 ET1000.7513
02:21 ET6810.7513
02:23 ET1000.7412
02:27 ET2000.7396
02:34 ET1000.7396
02:36 ET11000.7391
02:45 ET1000.7458
02:59 ET2000.7464
03:01 ET2000.7463
03:03 ET9230.7328
03:06 ET108120.7401
03:14 ET1500.732946
03:19 ET1000.7328
03:21 ET1400.7401
03:24 ET2830.7479
03:26 ET2000.733
03:32 ET5000.74395
03:33 ET28230.7606
03:37 ET8000.7559
03:44 ET26680.7591
03:46 ET1000.7581
03:50 ET2420.7557
03:51 ET4000.7599
03:53 ET42570.7618
03:55 ET38410.7647
03:57 ET21700.768
04:00 ET17190.7694
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNGM
NGM Biopharmaceuticals Inc
63.6M
-0.4x
---
United StatesSPRO
Spero Therapeutics Inc
62.0M
143.0x
---
United StatesCSBR
Champions Oncology Inc
71.4M
-9.5x
---
United StatesCNTG
Centogene NV
34.3M
-0.8x
---
United StatesAFMD
Affimed NV
67.2M
-0.5x
---
United StatesATRA
Atara Biotherapeutics Inc
66.0M
-0.2x
---
As of 2023-12-02

Company Information

NGM Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel, potentially life-changing medicines based on scientific understanding of key biological pathways underlying grievous diseases with critical unmet or underserved patient need. The Company’s portfolio of product candidates includes NGM707, NGM831, NGM438, NGM120, NGM621, aldafermin, NGM936 and MK-3655. NGM707 is a dual antagonist monoclonal antibody that is designed to improve patient immune responses to tumors by inhibiting both Immunoglobulin-like transcript 2 (ILT2) and Immunoglobulin-like transcript 4 (ILT4). The Company's NGM831 is an antagonist antibody that is designed to block the interaction of Immunoglobulin-like transcript 3 (ILT3) with fibronectin, as well as other cognate ligands. NGM438 is an antagonist antibody that is designed to inhibit leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) and promote anti-tumor immune responses.

Contact Information

Headquarters
333 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1978
Phone
650-243-5555
Fax
650-583-1646

Executives

Chairman of the Board
William Rieflin
Chief Executive Officer, Director
David Woodhouse
Chief Financial Officer
Jean - Frederic Viret
Executive Vice President, Chief Medical Officer
Hsiao Lieu
Senior Vice President, Chief Accounting Officer, Chief Compliance Officer, General Counsel, Company Secretary
Valerie Pierce

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$63.6M
Revenue (TTM)
$22.4M
Shares Outstanding
82.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.21
EPS
$-1.84
Book Value
$3.17
P/E Ratio
-0.4x
Price/Sales (TTM)
2.8
Price/Cash Flow (TTM)
---
Operating Margin
-713.67%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.